About 79% of clinical trial participants experienced measurable improvement after receiving experimental, CRISPR-based gene editing that is designed to fix a rare form of blindness, according to a paper published in the New England Journal of Medicine.
The Quintuple Aim: Redefining Patient-Centered Care in the Digital Age
Prashila Dullabh, VP & Senior Fellow, Health Sciences and Director, Health Implementation Science Center at NORC at the University of Chicago Patient-centered care is constantly